-
Je něco špatně v tomto záznamu ?
Highly effective Ru(II) and Os(II) half-sandwich complexes induce cytotoxicity in cancer cells through combined mitochondrial and endoplasmic reticulum stress
J. Hošek, K. Petrželová, R. Héžová, N. Straková, S. Kajabová, I. Nemec, P. Šimečková, K. Pěnčíková, J. Mašek, J. Moncoľ, P. Štarha
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články
- MeSH
- komplexní sloučeniny * farmakologie chemie chemická syntéza MeSH
- lidé MeSH
- mitochondrie * účinky léků metabolismus MeSH
- molekulární struktura MeSH
- nádorové buněčné linie MeSH
- organokovové sloučeniny * farmakologie chemie chemická syntéza MeSH
- osmium * chemie farmakologie MeSH
- proliferace buněk účinky léků MeSH
- protinádorové látky * farmakologie chemie chemická syntéza MeSH
- reaktivní formy kyslíku metabolismus MeSH
- ruthenium * chemie farmakologie MeSH
- screeningové testy protinádorových léčiv MeSH
- stres endoplazmatického retikula * účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
A series of ruthenium(II) and osmium(II) half-sandwich complexes was synthesized and characterized for its potential as a new class of anticancer agents. The complexes feature polycyclic aromatic hydrocarbon (PAH)-substituted Schiff bases and were rationally designed to combine the redox-modulating MoA of half-sandwich Ru, Rh, Os and Ir complexes, connected with their ability to induce the formation of various reactive oxygen species (ROS), with the ability of PAH-substituents to target and disrupt DNA. The complexes [Ru(η6-pcym)Cl(L)]PF6 (1-4) and [Os(η6-pcym)Cl(L)]PF6 (5-8) were stable in aqueous environments, in contrast to the rapid degradation observed for the co-studied rhodium(III) (9-12) and iridium(III) (13-16) [M(η5-Cp∗)Cl(L)]PF6 complexes; L = ethane-1,2-diamine-based Schiff bases (L1-L4) bearing two terminal PAH substituents 2-naphtyl (for L1), 9-anthracenyl (for L2), 9-phenanthrenyl (L3) or 1-pyrenyl (L4); pcym = 1-methyl-4-(propan-2-yl)benzene (p-cymene), Cp∗ = pentamethylcyclopentadienyl. Biological testing demonstrated that 1-8 possess significant antiproliferative activity against various lung cancer cell lines, including those resistant to cisplatin, with Os(II) complex 5 showing the highest cytotoxicity. Treatment with these complexes led to the activation of stress-related gene pathways, including unconventional endoplasmic reticulum stress, apoptotic signalling, and mitochondrial membrane depolarization. Activation of p21/GADD45A pathway indicates DNA-damage response, as well. Notably, these complexes did not induce significant inflammatory responses, a notable advantage over cisplatin. The results highlight the potential of Ru and Os half-sandwich complexes as alternative metallodrugs, capable of overcoming platinum resistance and minimizing inflammatory side effects. This study suggests that these compounds could serve as a promising class of anticancer agents for future clinical development.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25021372
- 003
- CZ-PrNML
- 005
- 20251023075616.0
- 007
- ta
- 008
- 251014e20250711fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejmech.2025.117970 $2 doi
- 035 __
- $a (PubMed)40701010
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Hošek, Jan $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic. Electronic address: jan.hosek@vri.cz
- 245 10
- $a Highly effective Ru(II) and Os(II) half-sandwich complexes induce cytotoxicity in cancer cells through combined mitochondrial and endoplasmic reticulum stress / $c J. Hošek, K. Petrželová, R. Héžová, N. Straková, S. Kajabová, I. Nemec, P. Šimečková, K. Pěnčíková, J. Mašek, J. Moncoľ, P. Štarha
- 520 9_
- $a A series of ruthenium(II) and osmium(II) half-sandwich complexes was synthesized and characterized for its potential as a new class of anticancer agents. The complexes feature polycyclic aromatic hydrocarbon (PAH)-substituted Schiff bases and were rationally designed to combine the redox-modulating MoA of half-sandwich Ru, Rh, Os and Ir complexes, connected with their ability to induce the formation of various reactive oxygen species (ROS), with the ability of PAH-substituents to target and disrupt DNA. The complexes [Ru(η6-pcym)Cl(L)]PF6 (1-4) and [Os(η6-pcym)Cl(L)]PF6 (5-8) were stable in aqueous environments, in contrast to the rapid degradation observed for the co-studied rhodium(III) (9-12) and iridium(III) (13-16) [M(η5-Cp∗)Cl(L)]PF6 complexes; L = ethane-1,2-diamine-based Schiff bases (L1-L4) bearing two terminal PAH substituents 2-naphtyl (for L1), 9-anthracenyl (for L2), 9-phenanthrenyl (L3) or 1-pyrenyl (L4); pcym = 1-methyl-4-(propan-2-yl)benzene (p-cymene), Cp∗ = pentamethylcyclopentadienyl. Biological testing demonstrated that 1-8 possess significant antiproliferative activity against various lung cancer cell lines, including those resistant to cisplatin, with Os(II) complex 5 showing the highest cytotoxicity. Treatment with these complexes led to the activation of stress-related gene pathways, including unconventional endoplasmic reticulum stress, apoptotic signalling, and mitochondrial membrane depolarization. Activation of p21/GADD45A pathway indicates DNA-damage response, as well. Notably, these complexes did not induce significant inflammatory responses, a notable advantage over cisplatin. The results highlight the potential of Ru and Os half-sandwich complexes as alternative metallodrugs, capable of overcoming platinum resistance and minimizing inflammatory side effects. This study suggests that these compounds could serve as a promising class of anticancer agents for future clinical development.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a ruthenium $x chemie $x farmakologie $7 D012428
- 650 12
- $a protinádorové látky $x farmakologie $x chemie $x chemická syntéza $7 D000970
- 650 12
- $a osmium $x chemie $x farmakologie $7 D009992
- 650 12
- $a stres endoplazmatického retikula $x účinky léků $7 D059865
- 650 12
- $a mitochondrie $x účinky léků $x metabolismus $7 D008928
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a molekulární struktura $7 D015394
- 650 12
- $a komplexní sloučeniny $x farmakologie $x chemie $x chemická syntéza $7 D056831
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 12
- $a organokovové sloučeniny $x farmakologie $x chemie $x chemická syntéza $7 D009942
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Petrželová, Kamila $u Department of Inorganic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 12, 77146, Olomouc, Czech Republic
- 700 1_
- $a Héžová, Renata $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
- 700 1_
- $a Straková, Nicol $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
- 700 1_
- $a Kajabová, Simona $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
- 700 1_
- $a Nemec, Ivan $u Department of Inorganic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 12, 77146, Olomouc, Czech Republic
- 700 1_
- $a Šimečková, Pavlína $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
- 700 1_
- $a Pěnčíková, Kateřina $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
- 700 1_
- $a Mašek, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
- 700 1_
- $a Moncoľ, Ján $u Department of Inorganic Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Bratislava, SK-81237, Slovakia
- 700 1_
- $a Štarha, Pavel $u Department of Inorganic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 12, 77146, Olomouc, Czech Republic. Electronic address: pavel.starha@upol.cz
- 773 0_
- $w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 297 (20250711), s. 117970
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40701010 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20251014 $b ABA008
- 991 __
- $a 20251023075622 $b ABA008
- 999 __
- $a ok $b bmc $g 2416668 $s 1259535
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 297 $c - $d 117970 $e 20250711 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a Pubmed-20251014